Insight Molecular Diagnostics Inc. (IMDX)

IMDX Revenue

Insight Molecular Diagnostics had revenue of $2.14M in the quarter ending March 31, 2025, with 1,114.77% growth. This brings the company's revenue in the last twelve months to $3.84M, up 178.08% year-over-year. In the year 2024, Insight Molecular Diagnostics had annual revenue of $1.88M with 25.15% growth.

• Revenue (ttm): $3.84M
• Revenue Growth: +178.08%
• P/S Ratio: 11.43
• Revenue / Employee: $78,429
• Employees: 49
• Market Cap: 74.36M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.88M	378.00K	25.15%
Dec 31, 2023	1.50M	545.00K	56.89%
Dec 31, 2022	958.00K	-1.24M	-56.41%
Dec 31, 2021	2.20M	982.00K	80.76%
Dec 31, 2020	1.22M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.